Epigenica
PrivateLast Round
Grant
Sep 8, 2025
Total Funding Raised
$2.73M
Momentum Score
25 /100
Company Overview
Epigenica is a biotechnology company that provides a high-throughput epigenetic screening platform for biomedical research, drug discovery, and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epigenica Comps
Public and private peers based on sector, stage, and business model.
Epigenica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 8, 2025 | ||||
| Seed | Jun 30, 2025 |
Key People
Founding team and executive leadership
Epigenica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leksell Social Ventures | Seed |
| Navigare Ventures | Seed |
| Almi Invest AB | Seed |
| Voima Ventures | Seed |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Partnered with PrimeTech to expand presence in Japan.
- Jan 1, 2026
Plans to release kit products and a service arm in 2026.
Epigenica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epigenica's valuation, stock price, and market status.
